Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Functional integrity of benzodiazepine receptors of the geniculo-striate visual pathways in Creutzfeldt-Jakob disease

A pharmacological evoked potential study

Abstract

We evaluated the effects of flumazenil (FMZ), a high-affinity benzodiazepine receptor antagonist, on flash-evoked visual potentials (FEPs) in a patient with Creutzfeldt-Jacob disease (CJD). FEPs were recorded in three different consecutive sessions: (1) basal condition, without any pharmacological treatment; (2) 3.5 min after i.v. administration of 5 mg FMZ; (3) 1 min after i.v. administration of 10mg diazepam (DZP). FMZ provoked a marked increase in the amplitude as well as evident shortening of the latency of early FEP components. DZP reversed these effects. These results are in agreement with our previous findings of anatomical and functional integrity of the geniculo-striate pathways in human CJD and demonstrate functional integrity of benzodiazepine receptors in this visual system in CJD.

This is a preview of subscription content, log in to check access.

We’re sorry, something doesn't seem to be working properly.

Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

References

  1. 1.

    Aguglia U, Farnarier G, Régis H, Oliveri RL, Quattrone A (1990) Sensory evoked potentials in Creutzfeldt-Jakob disease. Eur Neurol 30:157–161

  2. 2.

    Aguglia U, Gambarelli D, Farnarier G, Quattrone A (1991) Different susceptibility of the geniculate and extrageniculate visual pathways to human Creutzfeldt-Jakob disease (a combined neurophysiological-neuropathological study). Electroencephalogr Clin Neurophysiol 78:413–423

  3. 3.

    Biggio G, Guarnieri P, Corda MG (1981) Benzodiazepine and GABA receptors in the retina: effect of light and dark adaption. Brain Res 216:210–214

  4. 4.

    Brown P, Cathala F, Castaigne P, Gajdusek DC (1986) Creutzfeldt-Jakob disease: clinical analysis of a consecutive series of 230 neuropathologically verified cases. Ann Neurol 20:597–602

  5. 5.

    Burke DA, Mitchell KW, Mardini HA, Record CO (1988) Reversal of hepatic coma with flumazenil with improvement in visual evoked potentials. Lancet I:505–506

  6. 6.

    Haefely W (1983) Antagonists of benzodiazepines: functional aspects. In: Biggio G, Costa E (eds) Benzodiazepine recognition site ligands: biochemistry and pharmacology. Raven Press, New York, pp 73–93

  7. 7.

    Hendry SH, Fuchs J, De Blas AL, Jones EG (1990) Distribution and plasticity of immunocytochemically localized GABA A receptors in adult monkey visual cortex. J Neurosci 10:2438–2450

  8. 8.

    Klotz U, Kanto J (1988) Pharmacokinetics and clinical use of flumazenil (RO 15-1788). Clin Pharmacokinet 14:1–12

  9. 9.

    Kraut MA, Arezzo JC, Vaughan HG Jr (1985) Intracortical generators of the flash VEP in monkeys. Electroencephalogr Clin Neurophysiol 62:300–312

  10. 10.

    Kraut MA, Arezzo JC, Vaughan HG Jr (1990) Inhibitory processes in the flash evoked potential of the monkey. Electroencephalogr Clin Neurophysiol 76:440–452

  11. 11.

    Lee RG, Blair RDG (1973) Evolution of EEG and visual evoked response changes in Jakob-Creutzfeldt disease. Electroencephalogr Clin Neurophysiol 35:133–142

  12. 12.

    Lugaresi E, Medori R, Montagna P, Baruzzi A, Cortelli P, Lugaresi A, Tinuper P, Zucconi M, Gambetti P (1986) Fatal familial insomnia and dysautonomia with selective degeneration of thalamic nuclei. N Engl J Med 315:997–1003

  13. 13.

    Lupolover Y, Safran AB, Desangles D, Weisse C de, Meyer JJ, Bousquet A, Assimacopoulmos A (1984) Evaluation of visual function in healthy subjects after administration of RO 151788. Eur J Clin Pharmacol 27:505–507

  14. 14.

    Möler H, Richades JC (1981) Agonist and antagonist benzodiazepine receptor interaction in vivo. Nature 294-763-765

  15. 15.

    Murphy PC, Sillito AM (1989) The binocular input to cells in the feline dorsal lateral geniculate nucleus. J Physiol (Lond) 415:393–408

  16. 16.

    Savic I, Widén L, Stone-Elander S (1991) Feasibility of reversing benzodiazepine tolerance with flumazenil. Lancet 337:133–137

Download references

Author information

Correspondence to U. Aguglia.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Aguglia, U., Oliveri, R.L., Gambardella, A. et al. Functional integrity of benzodiazepine receptors of the geniculo-striate visual pathways in Creutzfeldt-Jakob disease. J Neurol 240, 25–27 (1993). https://doi.org/10.1007/BF00838442

Download citation

Key words

  • Creutzfeldt-Jacob disease
  • Diazepam
  • Flash-evoked visual potentials
  • Flumazenil
  • Gamma-aminobutyric acid